EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application

Thi Nhat Linh Phan, Thi Thuy Truong, Tan Hung Vo iD, Van Hiep Pham iD, Thi Xuan Nguyen, Thi Kim Ngan Duong iD, Vu Hoang Minh Doan, Jaeyeop Choi, Mrinmoy Misra iD, Junghwan Oh iD, Sudip Mondal iD

Materials · 22.05.2026 · 19 (11) · 2186

DOI: 10.3390/ma19112186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials, online erschienen am 22.05.2026. Verfasst von Thi Nhat Linh Phan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Industry 4.0 Convergence Bionics Engineering, Department of Biomedical Engineering, Pukyong National University, Busan 48513, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Pukyong National University, Korea government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three-dimensional (3D) bioprinting has rapidly evolved into a controlling platform for the fabrication of patient-specific biomedical implants, with growing importance in advanced drug delivery systems. Beyond structural tissue engineering, bioprinted constructs now function as programmable therapeutic depots capable of localized, sustained, and stimuli-responsive drug release. This review focuses on recent biomaterial design strategies that enable precise control over drug encapsulation, retention, and release kinetics within 3D bioprinted architectures. The physicochemical and mechanical properties of bioinks, including crosslinking density, porosity, degradation behavior, viscoelasticity, and swelling characteristics, directly influence drug loading efficiency and release dynamics under physiological conditions. The rational tuning of these parameters allows the development of constructs that provide spatially controlled and temporally regulated therapeutic delivery. Recent advances in predictive modeling, such as finite element modeling (FEM), data-driven machine learning approaches, and ML, have significantly improved the ability to correlate material composition, printing parameters, and structural geometry with drug diffusion and degradation-mediated release mechanisms. These tools facilitate the optimization of printing variables including extrusion pressure, nozzle diameter, and layer resolution to ensure structural fidelity while maintaining therapeutic functionality. Emerging strategies incorporating multi-material printing, gradient architectures, and stimuli-responsive biomaterials have expanded the potential of 3D bioprinting for combination therapies and personalized medicine. This review discusses key challenges in translating bioprinted drug delivery systems into clinical applications, including the standardization of drug release characterization methods, and long-term stability assessment.

Schlagwörter

Stichwörter der Autor:innen

3D printingbiomaterialscomputational modellingmechanical characterizationscaffoldstissue engineering

Autor:innen und Institutionen

  • Industry 4.0 Convergence Bionics Engineering, Department of Biomedical Engineering, Pukyong National University, Busan 48513, Republic of Korea.
  • Smart Gym-Based Translational Research Center for Active Senior's Healthcare, Pukyong National University, Busasn 48513, Republic of Korea.
  • Faculty of Mechanical Engineering and Mechatronics, PHENIKAA School of Engineering, PHENIKAA University, Nguyen Trac, Duong Noi, Hanoi 12116, Vietnam.
  • Mechatronics Engineering Department, School of Engineering, Manipal University Jaipur, Jaipur 303007, India.
  • Digital Healthcare Research Center, Institute of Information Technology and Convergence, Pukyong National University, Busan 48513, Republic of Korea.

ORCID-Profile: Tan Hung Vo, Van Hiep Pham, Thi Kim Ngan Duong, Mrinmoy Misra, Junghwan Oh, Sudip Mondal

Förderung

  • National Research Foundation of Korea
  • Pukyong National University
  • Korea government
  • Pukyong National University Industry-university Cooperation Foundation’s 2024 Post-Doc support project

Zitieren

APA

Phan, T. N. L., Truong, T. T., Vo, T. H., Pham, V. H., Nguyen, T. X., Duong, T. K. N., Doan, V. H. M., Choi, J., Misra, M., Oh, J., & Mondal, S. (2026). Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application. Materials, 19(11), 2186. https://doi.org/10.3390/ma19112186

Vancouver

Phan TNL, Truong TT, Vo TH, Pham VH, Nguyen TX, Duong TKN, et al. Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application. Materials. 2026;19(11):2186. doi:10.3390/ma19112186

BibTeX
@article{Phan2026,
  author = {Phan, Thi Nhat Linh and Truong, Thi Thuy and Vo, Tan Hung and Pham, Van Hiep and Nguyen, Thi Xuan and Duong, Thi Kim Ngan and Doan, Vu Hoang Minh and Choi, Jaeyeop and Misra, Mrinmoy and Oh, Junghwan and Mondal, Sudip},
  title = {Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application},
  journal = {Materials},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {2186},
  doi = {10.3390/ma19112186}
}
Kostenlos starten →